Economic Impact of Typhoid and Cost effectiveness of strategies for prevention Evaluation of Typhoid
World Health Organization has prequalified the use of typhoid conjugate vaccine (TCV) in children over six months of age in typhoid endemic countries. The present study assessed the cost-effectiveness of introducing TCV separately for urban and rural areas of India. From a societal perspective, introduction of TCV is a cost saving strategy in urban India. Further, due to low incidence of typhoid infection, introduction of TCV is not cost-effective in rural settings of India
Costing of Health Services in India (CHSI)
The ?Cost of Health Services in India (CHSI)? is the first large scale multi-site facility costing study to incorporate evidence from a national sample of both private and public sectors at different levels of the health system in India. A total of 38 public (11 tertiary care and 27 secondary care) and 16 private hospitals were sampled from 11 states of India. From the sampled facilities, a total of 327 specialties were included, with 48, 79 and 200 specialties covered in tertiary, private and district hospitals respectively. A mixed methodology consisting of both bottom-up and top-down costing was used for data collection.
Evaluation of the ?Bhai Ghanhya Sehat Sewa Scheme? (BGSSS) in the state of Punjab, India
Economic Assessment of health impact and economic costs associated with unsafe & unnecessary injections and unsafe biomedical waste disposal in Punjab state and for India.
Globally, 16 billion injections are administered each year of which 95% are for curative care. India contributes 25?30% of the global injection load. Over 63% of these injections are reportedly unsafe or deemed unnecessary. The objective of the current study was to assess the incremental cost per quality-adjusted life-year (QALY) gained with the introduction of safety-engineered syringes (SES) as compared to disposable syringes for therapeutic care in India. The study findings revealed that RUP syringes are estimated to be cost-effective in the Indian context. SIP and RUP?+?SIP syringes are not cost-effective at the current unit prices. Efforts should be made to bring down the price of SES to improve its cost-effectiveness
Comparative cost-effectiveness of nurse-mentoring models in India
Medical Technology Assessment Board Resource Centre
In order to promote transparent and evidence-informed decision-making in healthcare, the Government of India established the Health Technology Assessment in India (HTAIn) under the Department of Health Research (DHR), Ministry of Health and Family Welfare. The HTAIn Regional Resource Hub at the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, was initially set up in 2017 as the first Regional Resource Centre (RRC) of the HTAIn Secretariat, DHR, Ministry of Health and Family Welfare, Government of India. In 2024, it was further upgraded to the status of a Regional Resource Hub (RRH). Since its inception, the RRC has made substantial contributions to the development and strengthening of the HTA framework in India. Beyond conducting globally recognized HTA studies, it has played a pivotal role in building capacity, developing processes, and establishing guidelines and databases essential for the effective implementation of HTA across the country. In addition to supporting other technical partner institutes and RRCs in conducting their assigned HTA studies, the HTAIn-RRH at PGIMER has also contributed significantly to the work of the HTAIn Secretariat. It has organized a series of national and international conferences, workshops, and training programs aimed at advancing HTA practices. The evidence generated from the studies conducted by the HTAIn-RRH at PGIMER has resulted in numerous policy changes at both the central and state levels, leading to improved healthcare resource allocation and substantial cost savings.
Partnerships for Affordable Healthcare Access and Longevity (PAHAL)
Cost Effectiveness of Dimagi?s Commcare Program for Maternal and Child Healthcare
A variety of mobile-based health technologies (mHealth) have been developed for use by community health workers to augment their performance. One such mHealth intervention?ReMiND program, was implemented in a poor performing district of India. Despite some research on the extent of its effectiveness, there is significant dearth of evidence on cost-effectiveness of such mHealth interventions. In this research project we evaluated the incremental cost per disability adjusted life year (DALY) averted as a result of ReMiND intervention as compared to routine maternal and child health programs without ReMiND. Overall, findings of our study suggest strongly that the mHealth intervention as part of ReMiND program is cost saving from a societal perspective and should be considered for replication elsewhere in other states.
Economic Burden of RF/RHD and Cost Effectiveness of its Prevention Strategies in India
There is a dearth of evidence on the cost-effectiveness of a combination of population-based primary, secondary, and tertiary prevention and control strategies for rheumatic fever and rheumatic heart disease. The present research project was aimed to evaluate the cost-effectiveness and distributional effect of primary, secondary, and tertiary interventions and their combinations for the prevention and control of rheumatic fever and rheumatic heart disease in India. The combined secondary and tertiary prevention and control strategy is the most cost-effective option for the management of rheumatic fever and rheumatic heart disease in India, and the benefits of public spending are likely to be accrued much more by those in the lowest income groups. The quantification of non-health gains provides strong evidence for informing policy decisions by efficient resource allocation on rheumatic fever and rheumatic heart disease prevention and control in India.
National Highway Accident Relief Service Scheme (NHARSS) and cashless scheme of health insurance for road accident victims